PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Danderyd hospital, Stockholm, Sweden.\', \'Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.\', \'Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.\', \'Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden.\', \'Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.\', \'Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden. charlotte.thalin@sll.se.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-020-18848-0
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33033249
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all